Literature DB >> 24375645

RNA-binding protein RBM24 regulates p63 expression via mRNA stability.

Enshun Xu1, Jin Zhang, Min Zhang, Yuqian Jiang, Seong-Jun Cho, Xinbin Chen.   

Abstract

UNLABELLED: p63, a p53 family member, plays pivotal roles in epidermal development, aging, and tumorigenesis. Thus, understanding how p63 expression is controlled has biological and clinical importance. RBM24 is an RNA-binding protein and shares a high sequence similarity with RBM38, a critical regulator of p63. In this study, we investigated whether RBM24 is capable of regulating p63 expression. Indeed, we found that ectopic expression of RBM24 decreased, whereas knockdown of RBM24 increased, the levels of p63 transcript and protein. To explore the underlying mechanism, we found that RBM24 was able to bind to multiple regions in the p63 3' untranslated region and, subsequently, destabilize p63 transcript. Furthermore, we showed that the 3' untranslated region in p63 transcript and the RNA-binding domain in RBM24 were required for RBM24 to bind p63 transcript and consequently, inhibit p63 expression. Taken together, our data provide evidence that RBM24 is a novel regulator of p63 via mRNA stability. IMPLICATIONS: Our study suggests that p63 is regulated by RBM24 via mRNA stability, which gives an insight into understanding how posttranscriptional regulatory mechanisms contribute to p63 expression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24375645      PMCID: PMC3962715          DOI: 10.1158/1541-7786.MCR-13-0526

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  45 in total

1.  p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development.

Authors:  A Yang; R Schweitzer; D Sun; M Kaghad; N Walker; R T Bronson; C Tabin; A Sharpe; D Caput; C Crum; F McKeon
Journal:  Nature       Date:  1999-04-22       Impact factor: 49.962

2.  p63 is a p53 homologue required for limb and epidermal morphogenesis.

Authors:  A A Mills; B Zheng; X J Wang; H Vogel; D R Roop; A Bradley
Journal:  Nature       Date:  1999-04-22       Impact factor: 49.962

3.  Positive and negative regulation of deltaN-p63 promoter activity by p53 and deltaN-p63-alpha contributes to differential regulation of p53 target genes.

Authors:  David Christopher Harmes; Edward Bresnick; Emma A Lubin; Julie K Watson; Kelly E Heim; Joshua C Curtin; Anne M Suskind; Justin Lamb; James DiRenzo
Journal:  Oncogene       Date:  2003-10-23       Impact factor: 9.867

4.  p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.

Authors:  A Yang; M Kaghad; Y Wang; E Gillett; M D Fleming; V Dötsch; N C Andrews; D Caput; F McKeon
Journal:  Mol Cell       Date:  1998-09       Impact factor: 17.970

5.  AIS is an oncogene amplified in squamous cell carcinoma.

Authors:  K Hibi; B Trink; M Patturajan; W H Westra; O L Caballero; D E Hill; E A Ratovitski; J Jen; D Sidransky
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

6.  Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma.

Authors:  Mira Heinonen; Petri Bono; Kirsi Narko; Sung-Hee Chang; Johan Lundin; Heikki Joensuu; Henry Furneaux; Timothy Hla; Caj Haglund; Ari Ristimäki
Journal:  Cancer Res       Date:  2005-03-15       Impact factor: 12.701

7.  The unique NH2-terminally deleted (DeltaN) residues, the PXXP motif, and the PPXY motif are required for the transcriptional activity of the DeltaN variant of p63.

Authors:  E Scott Helton; Jianhui Zhu; Xinbin Chen
Journal:  J Biol Chem       Date:  2005-11-30       Impact factor: 5.157

Review 8.  The common and distinct target genes of the p53 family transcription factors.

Authors:  K Harms; S Nozell; X Chen
Journal:  Cell Mol Life Sci       Date:  2004-04       Impact factor: 9.261

9.  Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability.

Authors:  Mario Hermsen; Cindy Postma; Jan Baak; Marjan Weiss; Anna Rapallo; Andrea Sciutto; Guido Roemen; Jan-Willem Arends; Richard Williams; Walter Giaretti; Anton De Goeij; Gerrit Meijer
Journal:  Gastroenterology       Date:  2002-10       Impact factor: 22.682

10.  Pirh2 E3 ubiquitin ligase modulates keratinocyte differentiation through p63.

Authors:  Yong-Sam Jung; Yingjuan Qian; Wensheng Yan; Xinbin Chen
Journal:  J Invest Dermatol       Date:  2012-12-13       Impact factor: 8.551

View more
  30 in total

1.  Serine 195 phosphorylation in the RNA-binding protein Rbm38 increases p63 expression by modulating Rbm38's interaction with the Ago2-miR203 complex.

Authors:  Yanhong Zhang; Xiuli Feng; Wenqiang Sun; Jin Zhang; Xinbin Chen
Journal:  J Biol Chem       Date:  2018-12-19       Impact factor: 5.157

Review 2.  RBM38 in cancer: role and mechanism.

Authors:  Cheng Zou; Ying Wan; Lingjing He; Jin Hai Zheng; Yang Mei; Junfeng Shi; Min Zhang; Zhiqiang Dong; Dingxiao Zhang
Journal:  Cell Mol Life Sci       Date:  2020-07-08       Impact factor: 9.261

3.  Iron Regulatory Protein 2 Exerts its Oncogenic Activities by Suppressing TAp63 Expression.

Authors:  Yanhong Zhang; Xiuli Feng; Jin Zhang; Xinbin Chen
Journal:  Mol Cancer Res       Date:  2020-04-10       Impact factor: 5.852

4.  The master transcription factor SOX2, mutated in anophthalmia/microphthalmia, is post-transcriptionally regulated by the conserved RNA-binding protein RBM24 in vertebrate eye development.

Authors:  Soma Dash; Lindy K Brastrom; Shaili D Patel; C Anthony Scott; Diane C Slusarski; Salil A Lachke
Journal:  Hum Mol Genet       Date:  2020-03-13       Impact factor: 6.150

5.  Rbm24, a target of p53, is necessary for proper expression of p53 and heart development.

Authors:  Min Zhang; Yanhong Zhang; Enshun Xu; Shakur Mohibi; Danielle Michelle de Anda; Yuqian Jiang; Jin Zhang; Xinbin Chen
Journal:  Cell Death Differ       Date:  2018-01-22       Impact factor: 15.828

6.  Modulation of the p53 family network by RNA-binding proteins.

Authors:  Chris Lucchesi; Jin Zhang; Xinbin Chen
Journal:  Transl Cancer Res       Date:  2016-12       Impact factor: 1.241

7.  ALS-associated KIF5A mutations abolish autoinhibition resulting in a toxic gain of function.

Authors:  Desiree M Baron; Adam R Fenton; Sara Saez-Atienzar; Anthony Giampetruzzi; Aparna Sreeram; Pamela J Keagle; Victoria R Doocy; Nathan J Smith; Eric W Danielson; Megan Andresano; Mary C McCormack; Jaqueline Garcia; Valérie Bercier; Ludo Van Den Bosch; Jonathan R Brent; Claudia Fallini; Bryan J Traynor; Erika L F Holzbaur; John E Landers
Journal:  Cell Rep       Date:  2022-04-05       Impact factor: 9.995

Review 8.  Cancer the'RBP'eutics-RNA-binding proteins as therapeutic targets for cancer.

Authors:  Shakur Mohibi; Xinbin Chen; Jin Zhang
Journal:  Pharmacol Ther       Date:  2019-07-11       Impact factor: 12.310

9.  Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers.

Authors:  Yiduo Liu; Linxin Teng; Shiyi Fu; Guiyang Wang; Zhengjun Li; Chao Ding; Haodi Wang; Lei Bi
Journal:  BMC Cancer       Date:  2021-05-31       Impact factor: 4.430

10.  RBM24 suppresses cancer progression by upregulating miR-25 to target MALAT1 in nasopharyngeal carcinoma.

Authors:  Wen-Feng Hua; Qian Zhong; Tian-Liang Xia; Qi Chen; Mei-Yin Zhang; Ai-Jun Zhou; Zi-Wei Tu; Chen Qu; Man-Zhi Li; Yun-Fei Xia; Hui-Yun Wang; Dan Xie; Francois-Xavier Claret; Er-Wei Song; Mu-Sheng Zeng
Journal:  Cell Death Dis       Date:  2016-09-01       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.